Welcome to Mammotome
Mammotome is committed to advancing technology to help clinicians accurately diagnose breast disease, such as breast cancer, through minimally invasive procedures. As the global market leader in vacuum-assisted breast biopsy, Mammotome has offered physicians and women a wide range of options and diagnostic tools since 1995.
The Mammotome® Biopsy System is a complete system for breast tissue sampling and management. Compatible with multiple imaging modalities, the Mammotome® Biopsy System enables breast biopsy to be performed under stereotactic x-ray, ultrasound, MRI or molecular imaging guidance. Mammotome offers a full array of tissue markers to mark the biopsy site for follow-up observations.
With the Mammotome® Biopsy System, clinicians can achieve diagnostic confidence using a less invasive approach that offers women faster recovery, less scarring and lower costs of care as compared to open procedures.
INTRODUCING – Mammotome® revolve™
The only device to offer advanced tissue management technology, it is designed to empower clinical decision making, increase procedural efficiency and provide optimized sample reliability. Mammotome® revolve™ puts information ease and clinical reassurance at your fingertips.
Mammotome® revolve™ is a new vacuum-assisted biopsy platform for a new generation.